Anney Mannancheril, MD

Dr. Mittelman has vast clinical, research and academic leadership experience. Through numerous teaching hospital appointments and as the lead researcher of hundreds of clinical trials, Dr. Mittelman has collectively authored or co-authored close to 400 peer-reviewed manuscripts, abstracts and book chapters - the bulk of them focused on new treatment modalities for cancer, including emerging medications and how to stimulate the immune system to attack tumors.

Dr. Vainshtein leads WPH's stereotactic radiosurgery program and specializes in the management of head and neck, lung, esophageal, prostate, bladder, pancreaticobiliary, liver, stomach, anorectal, and brain and spine cancers, with experience in the treatment of lymphomas, sarcomas, breast, and gynecological cancers. He has expertise in the use of numerous advanced radiotherapy treatment techniques, including intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), image guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), stereotactic ablative radiotherapy/stereotactic body radiotherapy (SABR/SBRT) and 3D-conformal radiotherapy (3D-CRT)

Sara Sadan, M.D. is the Section Chief for the Department of Medical Oncology at White Plains Hospital as well as the Director for Breast and Women’s Cancers. Dr. Sadan received her medical degree from